AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16299646 — intervention group
Group type: COMPARATOR
Intervention: 250 ml hydrochloric sodium before chemotherapy for 5 days (Control)
Number of subjects: 40
Study 16299646 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin treatment
Number of subjects: 40
Study 16299646 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 16299646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 12577189 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 30 mg intravenously every 3 months, combined with 1000 mg calcium and 1000 IU vitamin D per day.
Number of subjects: 34
Study 12577189 — intervention group
Group type: COMPARATOR
Intervention: Historical control group treated only with calcium and vitamin D.
Number of subjects: 34
Study 12577189 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate treatment.
Number of subjects: 34
Study 10235519 — intervention group
Group type: COMPARATOR
Intervention: Standard pancreaticoduodenectomy
Number of subjects: 114
Study 10235519 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical pancreaticoduodenectomy
Number of subjects: 114
Study 7758556 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen 25 mg before sleep
Number of subjects: 10
Study 7758556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2200894 — intervention group
Group type: EXPERIMENTAL
Intervention: 1988-1989 trivalent split-antigen influenza vaccine
Number of subjects: 336
Study 2200894 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 336
Study 367087 — intervention group
Group type: EXPERIMENTAL
Intervention: Quinidine Lipettes (sustained release preparation)
Number of subjects: 0
Study 367087 — intervention group
Group type: COMPARATOR
Intervention: Other quinidine preparations on the Swedish market
Number of subjects: 0
Study 31155604 — intervention group
Group type: EXPERIMENTAL
Intervention: PtCr-EES
Number of subjects: 3755
Study 31155604 — intervention group
Group type: COMPARATOR
Intervention: CoCr-ZES
Number of subjects: 3755
Study 28880935 — intervention group
Group type: EXPERIMENTAL
Intervention: 32-minute walking test (32MWT)
Number of subjects: 17
Study 25830813 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Cigarette-High Tar (TCH)
Number of subjects: 20
Study 25830813 — intervention group
Group type: COMPARATOR
Intervention: Test Cigarette-Low Tar (TCL)
Number of subjects: 20
Study 23306361 — intervention group
Group type: EXPERIMENTAL
Intervention: Three injection techniques
Number of subjects: 0
Study 20841317 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional programme combining physical training, patient transfer techniques, and stress management
Number of subjects: 306
Study 20841317 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 306
Study 20841317 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 306
Study 19439456 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic biliopancreatic diversion with duodenal switch
Number of subjects: 60
Study 19439456 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux‐en‐Y gastric bypass
Number of subjects: 60
Study 17287106 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 14977662 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation
Number of subjects: 60
Study 14977662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 11426559 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripherally inserted central catheters (PICCs)
Number of subjects: 40
Study 9386028 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwives' unit
Number of subjects: 2844
Study 9386028 — intervention group
Group type: COMPARATOR
Intervention: Consultant-led labour ward
Number of subjects: 2844
Study 7970440 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenosine infusion at 140 micrograms kg‐1 min‐1
Number of subjects: 90
Study 7970440 — intervention group
Group type: COMPARATOR
Intervention: Adenosine infusion combined with low-level dynamic exercise
Number of subjects: 90
Study 3675695 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin + ambroxol 60 mg p.o.t.i.d.
Number of subjects: 14
Study 3675695 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin 1000 mg p.o.t.i.d.
Number of subjects: 14
Study 29572284 — intervention group
Group type: EXPERIMENTAL
Intervention: IV aminophylline 250 mg
Number of subjects: 126
Study 29572284 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 126
Study 26903399 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.625 mg/day of oral conjugated equine estrogen (CEE) for 3 months
Number of subjects: 45
Study 26903399 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg/day of oral 17β estradiol (E2) for 3 months
Number of subjects: 45
Study 26903399 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 μg/day of transdermal 17βE2 for 3 months
Number of subjects: 45
Study 25024243 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronically delivered decision support tools
Number of subjects: 603409
Study 25024243 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 603409
Study 23877659 — intervention group
Group type: EXPERIMENTAL
Intervention: TroVax plus docetaxel
Number of subjects: 25
Study 23877659 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel alone
Number of subjects: 25
Study 21211205 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intra-articular 25 mg etanercept injection
Number of subjects: 70
Study 21211205 — intervention group
Group type: COMPARATOR
Intervention: 2 ml compound betamethasone
Number of subjects: 70
Study 18831885 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming with a surgical access blanket
Number of subjects: 90
Study 18831885 — intervention group
Group type: COMPARATOR
Intervention: Forced air warming combined with an upper body blanket
Number of subjects: 90
Study 18831885 — intervention group
Group type: COMPARATOR
Intervention: Circulating water mattress
Number of subjects: 90
Study 17245238 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular reconstruction (patellar tendon autograft)
Number of subjects: 63
Study 17245238 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular reconstruction plus extra-articular quadricipital tendon plasty
Number of subjects: 63
Study 14974908 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg oestradiol and 0.5 mg norethisterone
Number of subjects: 50
Study 14974908 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 10801290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid (1 kcal/min)
Number of subjects: 9
Study 10801290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid (2 kcal/min)
Number of subjects: 9
Study 10801290 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid (3 kcal/min)
Number of subjects: 9
Study 10801290 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 9
Study 8668567 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam (0.2 mg/kg)
Number of subjects: 30
Study 8668567 — intervention group
Group type: COMPARATOR
Intervention: Oral hydroxyzine (3.7 mg/kg)
Number of subjects: 30
Study 8668567 — intervention group
Group type: COMPARATOR
Intervention: Control group (nitrous oxide)
Number of subjects: 30
Study 1601148 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG administered when the mean diameter of the largest follicle reached 18 mm (Group 1, n = 79)
Number of subjects: 247
Study 1601148 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG administered 1 day after criteria (Group 2, n = 84)
Number of subjects: 247
Study 1601148 — intervention group
Group type: EXPERIMENTAL
Intervention: hCG administered 2 days after criteria (Group 3, n = 84)
Number of subjects: 247
Study 6318605 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl preloading (5 micrograms/kg)
Number of subjects: 30
Study 6318605 — intervention group
Group type: COMPARATOR
Intervention: Control (no fentanyl preloading, received 4 mg/kg of thiopental)
Number of subjects: 30
Study 31201809 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterosacral ligament suspension
Number of subjects: 374
Study 31201809 — intervention group
Group type: COMPARATOR
Intervention: Sacrospinous ligament suspension
Number of subjects: 374
Study 31201809 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal native tissue repairs and midurethral sling
Number of subjects: 374
Study 28840301 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping
Number of subjects: 45
Study 28840301 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 45
Study 28840301 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 45
Study 26472349 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (utilisation of social networks for education)
Number of subjects: 0
Study 26472349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 26472349 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 0
Study 25016216 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care treatment model for depression
Number of subjects: 168
Study 25016216 — intervention group
Group type: COMPARATOR
Intervention: Public health Maternity Support Services (MSS)
Number of subjects: 168
Study 22868976 — intervention group
Group type: EXPERIMENTAL
Intervention: Unplugged intervention (12 lessons delivered during the 2007-2008 academic year)
Number of subjects: 1753
Study 22868976 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1753
Study 22868976 — intervention group
Group type: EXPERIMENTAL
Intervention: Unplugged intervention
Number of subjects: 1753
Study 22868976 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1753
Study 18622656 — intervention group
Group type: EXPERIMENTAL
Intervention: TNF‐GIF‐guided long tube insertion (LTI)
Number of subjects: 20
Study 18622656 — intervention group
Group type: COMPARATOR
Intervention: Conventional long tube insertion (LTI)
Number of subjects: 20
Study 17482925 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxylapatite (CaHA; Coaptite)
Number of subjects: 296
Study 17482925 — intervention group
Group type: COMPARATOR
Intervention: Bovine dermal collagen (Contigen)
Number of subjects: 296
Study 15112907 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg tid in conjunction with a comprehensive behavioral program
Number of subjects: 20
Study 11231366 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin containing 1 mg of folic acid for four weeks
Number of subjects: 81
Study 11231366 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B(12) 1 mg/day for an additional four weeks
Number of subjects: 81
Study 11231366 — intervention group
Group type: COMPARATOR
Intervention: High-dose folic acid (0, 5, or 20 mg) for four weeks
Number of subjects: 81
Study 9704681 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosinopril
Number of subjects: 285
Study 9704681 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 285
Study 7527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 0
Study 7527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosphenytoin
Number of subjects: 0
Study 7527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 7527321 — intervention group
Group type: EXPERIMENTAL
Intervention: Stiripentol
Number of subjects: 0
Study 2656096 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 g iv for three doses/8 h)
Number of subjects: 1319
Study 2656096 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin G (2 million U iv for four doses/6 h)
Number of subjects: 1319
Study 2656096 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic (control group)
Number of subjects: 1319
Study 29325594 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture at the sphenopalatine acupoint (SPA) with needle depth 50 mm
Number of subjects: 61
Study 29325594 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture with needle depth 20 mm
Number of subjects: 61
Study 26850798 — intervention group
Group type: EXPERIMENTAL
Intervention: Teucrium polium (250 mg q6h for the first 3 days of menstruation for two cycles)
Number of subjects: 70
Study 26850798 — intervention group
Group type: COMPARATOR
Intervention: Mefenamic acid (250 mg)
Number of subjects: 70
Study 25656524 — intervention group
Group type: EXPERIMENTAL
Intervention: 25-hydroxycholecalciferol (3 mg of Hidroferol, 180,000 IU)
Number of subjects: 94
Study 25656524 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual treatment for controlling Ca/P levels)
Number of subjects: 94
Study 23635344 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid balance charts (intervention group, n = 84)
Number of subjects: 170
Study 23635344 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 86) with access to fluid balance data
Number of subjects: 170
Study 23635344 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid balance charts (intervention group)
Number of subjects: 170
Study 23635344 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 170
Study 20045700 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 75 microg
Number of subjects: 310
Study 20045700 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 150 microg
Number of subjects: 310
Study 20045700 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 300 microg
Number of subjects: 310
Study 20045700 — intervention group
Group type: EXPERIMENTAL
Intervention: Linaclotide 600 microg
Number of subjects: 310
Study 20045700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study 18480689 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg/d (2 x 10 mg)
Number of subjects: 260
Study 18480689 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 15837245 — intervention group
Group type: EXPERIMENTAL
Intervention: TAXUS stent
Number of subjects: 1314
Study 15837245 — intervention group
Group type: EXPERIMENTAL
Intervention: TAXUS stent (insulin-requiring subgroup)
Number of subjects: 1314
Study 12534758 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 354
Study 12534758 — intervention group
Group type: COMPARATOR
Intervention: Consult-liaison care
Number of subjects: 354
Study 10937930 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 400
Study 10937930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 8522681 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril (angiotensin-converting enzyme inhibitor)
Number of subjects: 1434
Study 1884962 — intervention group
Group type: EXPERIMENTAL
Intervention: Hourly intravenous injections of 100 mg of cimetidine along with a continuous nasogastric infusion of a liquid antacid at the rate of 0.5 ml per minute
Number of subjects: 0
Study 6810994 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear magnetic resonance imaging
Number of subjects: 22
Study 31618605 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal (white bread, almonds)
Number of subjects: 7
Study 31618605 — intervention group
Group type: COMPARATOR
Intervention: Control meal (white bread, butter, cheese)
Number of subjects: 7
Study 30705584 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 120
Study 30705584 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 120
Study 28288595 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Yoga
Number of subjects: 65
Study 28288595 — intervention group
Group type: COMPARATOR
Intervention: Social support condition (control)
Number of subjects: 65
Study 26622078 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (1.0 mg/kg, up to 3 mg)
Number of subjects: 32
Study 26622078 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (placebo)
Number of subjects: 32
Study 23602205 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (25 mg elemental Zn/day)
Number of subjects: 44
Study 23602205 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 22473155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab and FLOX (arm B)
Number of subjects: 571
Study 22473155 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab combined with intermittent FLOX (arm C)
Number of subjects: 571
Study 22473155 — intervention group
Group type: COMPARATOR
Intervention: Standard Nordic FLOX (arm A)
Number of subjects: 571
Study 19480231 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training (three 60-minute, supervised, exercise sessions per week for 4 months)
Number of subjects: 25
Study 19480231 — intervention group
Group type: COMPARATOR
Intervention: No training (control) for 4 months
Number of subjects: 25
Study 16191068 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-hour alteplase (TPA) dwell
Number of subjects: 60
Study 16191068 — intervention group
Group type: EXPERIMENTAL
Intervention: > 48-hour alteplase (TPA) dwell
Number of subjects: 60
Study 12972682 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine
Number of subjects: 21
Study 11063377 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDCT) with autologous stem cell transplantation
Number of subjects: 0
Study 11063377 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose chemotherapy
Number of subjects: 0
Study 11063377 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDCT)
Number of subjects: 0
Study 8804944 — intervention group
Group type: EXPERIMENTAL
Intervention: NIVS with BiPAP (bilevel positive airway pressure) for 3 days (two daytime sessions of 3 hours each)
Number of subjects: 24
Study 8804944 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard treatment with oxygen, bronchodilators, and steroids)
Number of subjects: 24
Study 1998858 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy volunteers
Number of subjects: 48
Study 1998858 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy
Number of subjects: 48
Study 1998858 — intervention group
Group type: EXPERIMENTAL
Intervention: Truncal vagotomy and drainage
Number of subjects: 48
Study 1998858 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with diarrhoea
Number of subjects: 48
Study 1998858 — intervention group
Group type: COMPARATOR
Intervention: Asymptomatic patients
Number of subjects: 48
Study 1998858 — intervention group
Group type: COMPARATOR
Intervention: Other symptomatic patients
Number of subjects: 48
Study 6395281 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefonicid
Number of subjects: 76
Study 6395281 — intervention group
Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 76
Study 31859226 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Coaching (VC)
Number of subjects: 16
Study 31859226 — intervention group
Group type: COMPARATOR
Intervention: Conventional Teaching (CT)
Number of subjects: 16
Study 31583947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad containing 2 benefit outcomes and multiple risk categories
Number of subjects: 945
Study 31583947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad containing a single benefit outcome
Number of subjects: 945
Study 31583947 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad containing multiple risk categories
Number of subjects: 945
Study 31583947 — intervention group
Group type: COMPARATOR
Intervention: Ad containing a single risk category
Number of subjects: 945
Study 28245227 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified yoghurt (MNFY) with behavior change communication (BCC) campaign
Number of subjects: 449
Study 28245227 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving BCC only
Number of subjects: 449
Study 23800099 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified wheat flour chapatti
Number of subjects: 352
Study 23800099 — intervention group
Group type: COMPARATOR
Intervention: Wheat flour without added micronutrients (control)
Number of subjects: 352
Study 24921439 — intervention group
Group type: EXPERIMENTAL
Intervention: Trier Social Stress Test (TSST)
Number of subjects: 59
Study 24921439 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test (CPT)
Number of subjects: 59
Study 24921439 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test with Social Evaluation (CPT with SE)
Number of subjects: 59
Study 22411774 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group using orthographically biased stimuli and principles of motor learning (PML)
Number of subjects: 14
Study 22411774 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 14
Study 19327952 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential Compression Devices (SCDs)
Number of subjects: 150
Study 19327952 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous Foot Pumps (VFPs)
Number of subjects: 150
Study 19327952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Care Unit (ICU) admission
Number of subjects: 150
Study 19327952 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall compliance score
Number of subjects: 150
Study 18096809 — intervention group
Group type: EXPERIMENTAL
Intervention: Placement in foster care
Number of subjects: 0
Study 18096809 — intervention group
Group type: COMPARATOR
Intervention: Continued institutional care
Number of subjects: 0
Study 16169399 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU of recombinant human FSH on alternate days for 3 months
Number of subjects: 112
Study 16169399 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 112
Study 16169399 — intervention group
Group type: COMPARATOR
Intervention: Nonresponder group
Number of subjects: 112
Study 12891533 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily lysine acetylsalicylate (aspirin) 160 or 300 mg/day
Number of subjects: 272
Study 12891533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study 10554941 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual antenatal care plus smoking cessation intervention
Number of subjects: 732